Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

Summary

To evaluate the safety profile of alfimeprase as assessed by monitoring of adverse events, serious adverse events and major bleeding events for up to 120 minutes following the instillation of study drug to an occluded central venous access device.

Timeline

Start

2006-01

Primary completion

—

Completion

—

Drugs

Indications